Home/Bullfrog AI/Thomas Hazel
TH

Thomas Hazel

Vice President, Drug Development

Bullfrog AI

Bullfrog AI Pipeline

DrugIndicationPhase
BF-222Glioblastoma (initial), other cancersPreclinical
BF-223Glioblastoma, other oncology indicationsPreclinical
BF-114Obesity, NAFLD/NASH, MASLD, Hepatocellular Carcinoma (HCC)Preclinical